US Patent Issued to KYON BIOTECH on July 7 for "Asparaginase-based cancer therapy" (Swiss Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,092, issued on July 7, was assigned to KYON BIOTECH AG (Zurich, Switzerland).

"Asparaginase-based cancer therapy" was invented by Slobodan Tepic (Zurich, Switzerland) and Goran Cvetkovic (Rapperswil-Jona, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an improved preparation and delivery of asparaginase for use in medicine, e.g. in human and veterinary medicine."

The patent was filed on May 29, 2020, under Application No. 17/616,547.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsear...